Investigation of optimum hemoglobin levels in older patients with chronic kidney disease

被引:0
|
作者
Osman Kara
Pinar Soysal
Muharrem Kiskac
Lee Smith
Abdülkadir Karışmaz
Rumeyza Kazancioglu
机构
[1] Atasehir Medicana International Health Group,Department of Hematology
[2] Bezmialem Vakif University,Department of Geriatric Medicine, Faculty of Medicine
[3] Bezmialem Vakif University,Department of Internal Medicine, Faculty of Medicine
[4] Centre for Health,Department of Nephrology, Faculty of Medicine
[5] Performance and Wellbeing,undefined
[6] Anglia Ruskin University,undefined
[7] Istanbul Training and Research Hospital,undefined
[8] Clinic of Hematology,undefined
[9] Bezmialem Vakif University,undefined
关键词
Anemia; Chronic kidney disease; Hemoglobin; Elderly;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3055 / 3062
页数:7
相关论文
共 50 条
  • [31] PSYCHOLOGICAL STATUS IN OLDER PATIENTS WITH CHRONIC KIDNEY DISEASE
    Efremova, E.
    Shutov, A.
    [J]. ATHEROSCLEROSIS, 2021, 331 : E236 - E237
  • [32] The Epidemic Challenge of Chronic Kidney Disease in Older Patients
    Abdelhafiz, Ahmed H.
    Tan, Evelyn
    El Nahas, Meguid
    [J]. POSTGRADUATE MEDICINE, 2008, 120 (04) : 87 - 94
  • [33] Chronic kidney disease: CMV status affects hemoglobin levels and epoetin need
    Lucchese B.
    [J]. Nature Reviews Nephrology, 2010, 6 (3) : 127 - 127
  • [34] Urea levels and cardiovascular disease in patients with chronic kidney disease
    Laville, Solene M.
    Couturier, Aymeric
    Lambert, Oriane
    Metzger, Marie
    Mansencal, Nicolas
    Jacquelinet, Christian
    Laville, Maurice
    Frimat, Luc
    Fouque, Denis
    Combe, Christian
    Robinson, Bruce M.
    Stengel, Benedicte
    Liabeuf, Sophie
    Massy, Ziad A.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (01) : 184 - 192
  • [35] Association of adiposity with hemoglobin levels in patients with chronic kidney disease not on dialysis (vol 22, pg 638, 2018)
    Honda, Hirokazu
    Ono, Kota
    Akizawa, Tadao
    Nitta, Kosaku
    Hishida, Akira
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (06) : 1476 - 1476
  • [36] Darbepoetin alfa administration to achieve and maintain target hemoglobin levels for 1 year in patients with chronic kidney disease
    Hertel, Joachim E. W.
    Locay, Harold R.
    Scarlata, Debra S.
    Prathikanti, Radha
    Audhya, Paul K.
    [J]. MAYO CLINIC PROCEEDINGS, 2006, 81 (09) : 1188 - 1194
  • [37] Aranesp® (Darbepoetin alfa) administered once monthly maintains hemoglobin levels in patients with chronic kidney disease.
    Walczyk, M
    Agarwal, A
    Ling, B
    Carroll, W
    Liu, W
    Brenner, R
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 770A - 770A
  • [38] Aranesp® (Darbepoetin alfa) administered once monthly maintains hemoglobin levels in patients with chronic kidney disease (CKD).
    Agarwal, A
    Ling, B
    Walczyk, M
    Carroll, W
    Liu, W
    Brenner, R
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : A15 - A15
  • [39] VITAMIN A AND E LEVELS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Aksoy, Aziz
    Gozel, Nevzat
    Bulut-Arikan, Funda
    Kucuksu, Mehmet
    Ozdemir, Fethi Ahmet
    [J]. FRESENIUS ENVIRONMENTAL BULLETIN, 2018, 27 (10): : 7072 - 7078
  • [40] Glycated Hemoglobin and Outcomes in Patients with Advanced Diabetic Chronic Kidney Disease
    Kuo, I-Ching
    Lin, Hugo You-Hsien
    Niu, Sheng-Wen
    Hwang, Daw-Yang
    Lee, Jia-Jung
    Tsai, Jer-Chia
    Hung, Chi-Chih
    Hwang, Shang-Jyh
    Chen, Hung-Chun
    [J]. SCIENTIFIC REPORTS, 2016, 6